Grant: Joint Canada-Israel Health Research Program
Sunnybrook Research Institute (Toronto, Ontario)
$0.00
Deciphering the blueprint of the healthy and diseased human brain through the generation of patterned cerebral organoids
EF 2017-18
Résumé
The cerebral cortex is the region of the brain that allows us to sense the environment by sight, sound, touch, and smell, and to respond to it by movement or communication. The cerebral cortex also allows us to experience complex human emotions such as love, empathy, fear, and sadness. To perform these complex functions, this region of the brain is compartmentalized into primary sensory areas that are responsible for the senses of touch, hearing, and vision, and a primary motor area that controls movement. This partitioning is essential for normal functioning, and defects in regionalization may underlie certain diseases, such as autism spectrum disorder (ASD). The biggest challenge in studying neuropsychiatric disorders is that they often have their root causes in early embryonic development, making it near impossible to visualize the onset of disease, especially in humans. A ground-breaking new system has been developed to overcome this challenge, in which "cerebral organoids" that resemble the human brain can be cultured in a dish. Importantly, these cerebral organoids can be generated from a patient's own cells, so any genetic contributions to disease can be directly modeled. While the utility of studying these organoids is far-reaching, our proposal seeks to address a current limitation of cerebral organoid technology, which is that these organoids are likely not as well compartmentalized as the human brain. So that cerebral organoids can serve as a more robust model system to study human neurodevelopmental disorders, we have designed experimental strategies that are aimed at producing organoids that are properly partitioned, which we will use to better model brain deficits in disorders such as ASD.
Programme
Joint Canada-Israel Health Research Program
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
378880
Name
Schuurmans Carol J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Joint Canada-Israel Health Research Program
Projecttitle
Deciphering the blueprint of the healthy and diseased human brain through the generation of patterned cerebral organoids
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$0
Cihrequipment2
$0
Programname2
Joint Canada-Israel Health Research Program
Keyworddelim
Autism Spectrum Disorder; Cajal-Retzius Neurons; Cerebral Organoid; Crispr Gene Editing; Hippocampus; Morphogens; Motor, Visual, Auditory, Somatosensory; Primary Neocortical Areas; Regional Patterning; Thalamic Organoids/Explants
Abstract
The cerebral cortex is the region of the brain that allows us to sense the environment by sight, sound, touch, and smell, and to respond to it by movement or communication. The cerebral cortex also allows us to experience complex human emotions such as love, empathy, fear, and sadness. To perform these complex functions, this region of the brain is compartmentalized into primary sensory areas that are responsible for the senses of touch, hearing, and vision, and a primary motor area that controls movement. This partitioning is essential for normal functioning, and defects in regionalization may underlie certain diseases, such as autism spectrum disorder (ASD). The biggest challenge in studying neuropsychiatric disorders is that they often have their root causes in early embryonic development, making it near impossible to visualize the onset of disease, especially in humans. A ground-breaking new system has been developed to overcome this challenge, in which "cerebral organoids" that resemble the human brain can be cultured in a dish. Importantly, these cerebral organoids can be generated from a patient's own cells, so any genetic contributions to disease can be directly modeled. While the utility of studying these organoids is far-reaching, our proposal seeks to address a current limitation of cerebral organoid technology, which is that these organoids are likely not as well compartmentalized as the human brain. So that cerebral organoids can serve as a more robust model system to study human neurodevelopmental disorders, we have designed experimental strategies that are aimed at producing organoids that are properly partitioned, which we will use to better model brain deficits in disorders such as ASD.
Competitiondate
201802
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Schuurmans, Carol J; Reiner, Orly
Approvedterm
3 ans 0 mois